Actual Medicinal Product (AMP) Colesevelam 625mg tablets (Alliance Healthcare (Distribution) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA. Maximum 30 days in MCA.
Refer to individual SmPCs as manufacturer’s expiry after opening varies. No stability data in MCAs available. Original packaging may contain desiccant. Manufacturer recommends storing in original container.

Provenance

This recommendation is based on the products Cholestagel 625 mg film-coated tablets (Neon Healthcare Ltd) and Colesevelam hydrochloride 625 mg Film-Coated Tablets (Dr. Reddy's Laboratories (UK) Ltd).

Generic
Colesevelam
Formulation
Colesevelam 625mg tablets
  • Colesevelam
    • Colesevelam 625mg tablets

      • Colesevelam 625mg tablets (Alliance Healthcare (Distribution) Ltd)



Related Formulations (1)

compatible_special_measures logo Colesevelam 625mg tablets